CLINICAL_TRIALS
trial_result
· 2018-09-07
Clinical Trial Update: A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease [Phase 2]
Summary
Phase 2 clinical trial update for migalastat hydrochloride (AT1001) in Fabry disease completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amicus Therapeutics | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-09-07